TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+11.67%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$688M
AUM Growth
-$127M
(-16%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
47.84%
Holding
112
New
17
Increased
24
Reduced
32
Closed
23
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$19.3M |
| 2 |
Vaxcyte
PCVX
|
$14.4M |
| 3 |
Moderna
MRNA
|
$14.4M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
$13.1M |
| 5 |
BioAtla
BCAB
|
$9.55M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$42.3M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$21.2M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
$20.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
$18.1M |
| 5 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$14.9M |
Sector Composition
| 1 | Healthcare | 98.38% |
| 2 | Consumer Discretionary | 0.64% |
| 3 | Communication Services | 0% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Leap Therapeutics
LPTX
$11.7M
| – | – |
-125,000
| Closed | -$1.1M |
|
|
102
Rocket Pharmaceuticals
RCKT
$349M
| – | – |
-1,265,900
| Closed | -$20.2M |
|
|
SWTX
103
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-120,000
| Closed | -$3.42M |
|
104
Veru
VERU
$48.3M
| – | – |
-110,000
| Closed | -$12.7M |
|
105
Vanda Pharmaceuticals
VNDA
$274M
| – | – |
-256,696
| Closed | -$2.54M |
|
106
Q32 Bio
QTTB
$20.2M
| – | – |
-11,939
| Closed | -$346K |
|
|
RVNC
107
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-287,500
| Closed | -$7.76M |
|
|
DCFC
108
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| – | – |
-2,000
| Closed | -$1.28M |
|
|
BLU
109
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-200,000
| Closed | -$2.11M |
|
|
TWTR
110
DELISTED
Twitter, Inc.
TWTR
| – | – |
-300,000
| Closed | -$13.2M |
|
|
CCXI
111
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-50,000
| Closed | -$2.58M |
|
|
BHVN
112
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-280,000
| Closed | -$42.3M |
|